Skip to main content
OpenTrials
Completed

NCT Number: NCT05631990

A Study to Evaluate the Efficacy and Safety of AD-209

The purpose of this study is to evaluate the efficacy and safety of AD-209

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hypertension, Essential Cardiovascular Diseases Essential Hypertension Hypertension Vascular Diseases

Age range

19 year–74 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2

Primary location

Korea University Guro Hospital

Seoul, South Korea

About this study

Condition or disease : hypertension Intervention/treatment Drug : AD-209 Drug : AD-209-1A Drug : AD-209-1B Drug : AD-209-1C Drug : AD-209 Placebo Drug : AD-209-1 Placebo Phase : Phase 2

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Signed informed consent
  • Other inclusions applied

Exclusion criteria

  • orthostatic hypotension with symptom
  • Other exclusions applied

Treatment and study plan

AD-209

Drug

PO, Once daily(QD), 8weeks

AD-209-1A

Drug

PO, Once daily(QD), 8weeks

AD-209-1B

Drug

PO, Once daily(QD), 8weeks

AD-209-1C

Drug

PO, Once daily(QD), 8weeks

AD-209 placebo

Drug

PO, Once daily(QD), 8weeks

AD-209-1 placebo

Drug

PO, Once daily(QD), 8weeks

Primary outcomes

  1. Change rate of MSSBP

    Time frame: Baseline, Week 8

    Change from baseline in mean sitting systolic blood pressure

Sponsors and collaborators

Lead sponsor

Addpharma Inc.

Industry

Registry information

Official study title

A Randomized, Double-Blind, Parallel, Multi-Center, Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of AD-209 in Patients With Essential Hypertension

Important dates

Study start
2023
Primary completion
2023
Study completion
2023
First posted
Nov 30, 2022
Registry last updated
Apr 5, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.